University of Murcia research relating to P140

Summary by AI BETAClose X

ImmuPharma PLC has noted early-stage research from the University of Murcia published in Autophagy regarding the P140 peptide's potential in glioblastoma, which the company has been aware of since 2024. These findings support ImmuPharma's broader scientific work on P140, although the company's primary focus remains on advancing P140 for autoimmune disease.

Disclaimer*

Companies

Immupharma (IMM)
UK 100

Latest directors dealings